Literature DB >> 18094163

Probing the structural states of human immunodeficiency virus type 1 pr55gag by using monoclonal antibodies.

Jason J Leblanc1, Omar Perez, Thomas J Hope.   

Abstract

Gag-FP (fluorescent protein) fusion constructs are commonly used to study human immunodeficiency virus type 1 assembly, yielding diffuse signals throughout the cytoplasm along with punctate signals routinely described as virus-like particles (VLPs) representing assembled but unprocessed Gag. However, these particles cannot be accurately described as VLPs, since fluorescence microscopy cannot provide structural resolution. We demonstrate here that the inability of a monoclonal p24 antibody to bind its cognate epitope when unprocessed Gag is assembled distinguishes VLPs from unassembled, monomeric Gag. Furthermore, we show that assembled and unassembled Gag punctate signals travel along microtubules. These monoclonal antibody studies provide a new tool for examining retroviral assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094163      PMCID: PMC2258915          DOI: 10.1128/JVI.01717-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly.

Authors:  Xinhong Dong; Hua Li; Aaron Derdowski; Lingmei Ding; Atuhani Burnett; Xuemin Chen; Timothy R Peters; Terence S Dermody; Elvin Woodruff; Jaang-Jiun Wang; Paul Spearman
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

Review 2.  Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles.

Authors:  Marilyn D Resh
Journal:  AIDS Rev       Date:  2005 Apr-Jun       Impact factor: 2.500

3.  Novel chromophores and buried charges control color in mFruits.

Authors:  Xiaokun Shu; Nathan C Shaner; Corinne A Yarbrough; Roger Y Tsien; S James Remington
Journal:  Biochemistry       Date:  2006-08-15       Impact factor: 3.162

4.  Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.

Authors:  Candace Y Gomez; Thomas J Hope
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  The protein network of HIV budding.

Authors:  Uta K von Schwedler; Melissa Stuchell; Barbara Müller; Diane M Ward; Hyo-Young Chung; Eiji Morita; Hubert E Wang; Thaylon Davis; Gong-Ping He; Daniel M Cimbora; Anna Scott; Hans-Georg Kräusslich; Jerry Kaplan; Scott G Morham; Wesley I Sundquist
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

7.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.

Authors:  P Spearman; J J Wang; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.

Authors:  M Simm; M Shahabuddin; W Chao; J S Allan; D J Volsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.

Authors:  Stuart J D Neil; Scott W Eastman; Nolwenn Jouvenet; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2006-05-12       Impact factor: 6.823

View more
  8 in total

Review 1.  Microtubule Regulation and Function during Virus Infection.

Authors:  Mojgan H Naghavi; Derek Walsh
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.

Authors:  Shannon A Allen; Ann M Carias; Meegan R Anderson; Eneniziaogochukwu A Okocha; Lorie Benning; Michael D McRaven; Z L Kelley; John Lurain; Ronald S Veazey; Thomas J Hope
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Characterization of a monoclonal anti-capsid antibody that cross-reacts with three major primate lentivirus lineages.

Authors:  Brigitte E Sanders-Beer; Magdalena Eschricht; Janna Seifried; Vanessa M Hirsch; Jonathan S Allan; Stephen Norley
Journal:  Virology       Date:  2011-12-05       Impact factor: 3.616

Review 4.  HIV-1 assembly in macrophages.

Authors:  Philippe Benaroch; Elisabeth Billard; Raphaël Gaudin; Michael Schindler; Mabel Jouve
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

5.  Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel.

Authors:  Julie I Jay; Shetha Shukair; Kristofer Langheinrich; Melissa C Hanson; Gianguido C Cianci; Todd J Johnson; Meredith R Clark; Thomas J Hope; Patrick F Kiser
Journal:  Adv Funct Mater       Date:  2009-09-23       Impact factor: 18.808

6.  HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.

Authors:  Akira Ono
Journal:  Future Virol       Date:  2009       Impact factor: 1.831

7.  Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.

Authors:  Sho Sudo; Hiyori Haraguchi; Yoko Hirai; Hiroyuki Gatanaga; Jun-ichi Sakuragi; Fumitaka Momose; Yuko Morikawa
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 8.  Viral journeys on the intracellular highways.

Authors:  Makeda Robinson; Stanford Schor; Rina Barouch-Bentov; Shirit Einav
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.